Tech Company Financing Transactions
Meta Pharmaceuticals Funding Round
On 6/14/2022, Meta Pharmaceuticals received $15 million in Seed funding from IMO Ventures and Tiantu Capital.
Transaction Overview
Company Name
Announced On
6/14/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Block A Phase 1 Tianan Innovation and Technology Plaza No. 2 1201-B21
Shenzhen Guangdong, Undisclosed
China
Shenzhen Guangdong, Undisclosed
China
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
META Pharmaceuticals Inc. is a VC-backed early-stage company that is utilizing the power of metabolism to modulate the immune system to treat various diseases, including broad rages of autoimmune diseases and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xu Ke
Browse more venture capital transactions:
Prev: 6/14/2022: Clausematch venture capital transaction
Next: 6/14/2022: Onymos venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs